UBS Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,164,145
| Closed | -$215M | – | 7560 |
|
|
2019
Q3 | $215M | Sell |
2,164,145
-16,437
| -0.8% | -$1.63M | 0.08% | 188 |
|
|
2019
Q2 | $202M | Sell |
2,180,582
-2,629,135
| -55% | -$243M | 0.08% | 200 |
|
|
2019
Q1 | $454M | Buy |
4,809,717
+2,514,971
| +110% | +$237M | 0.19% | 112 |
|
|
2018
Q4 | $147M | Sell |
2,294,746
-1,365,558
| -37% | -$87.5M | 0.07% | 216 |
|
|
2018
Q3 | $328M | Buy |
3,660,304
+138,501
| +4% | +$12.4M | 0.13% | 144 |
|
|
2018
Q2 | $280M | Sell |
3,521,803
-422,085
| -11% | -$33.5M | 0.12% | 155 |
|
|
2018
Q1 | $352M | Sell |
3,943,888
-336,304
| -8% | -$30M | 0.15% | 129 |
|
|
2017
Q4 | $447M | Buy |
4,280,192
+1,087,228
| +34% | +$113M | 0.18% | 107 |
|
|
2017
Q3 | $466M | Sell |
3,192,964
-572,274
| -15% | -$83.4M | 0.22% | 91 |
|
|
2017
Q2 | $489M | Buy |
3,765,238
+386,159
| +11% | +$50.2M | 0.25% | 82 |
|
|
2017
Q1 | $420M | Buy |
3,379,079
+498,927
| +17% | +$62.1M | 0.23% | 88 |
|
|
2016
Q4 | $333M | Buy |
2,880,152
+33,384
| +1% | +$3.86M | 0.18% | 110 |
|
|
2016
Q3 | $298M | Buy |
2,846,768
+3,491
| +0.1% | +$365K | 0.18% | 115 |
|
|
2016
Q2 | $280M | Buy |
2,843,277
+149,151
| +6% | +$14.7M | 0.18% | 118 |
|
|
2016
Q1 | $270M | Sell |
2,694,126
-561,384
| -17% | -$56.2M | 0.18% | 115 |
|
|
2015
Q4 | $390M | Buy |
3,255,510
+426,328
| +15% | +$51.1M | 0.25% | 70 |
|
|
2015
Q3 | $306M | Sell |
2,829,182
-327,094
| -10% | -$35.4M | 0.22% | 87 |
|
|
2015
Q2 | $365M | Sell |
3,156,276
-154,714
| -5% | -$17.9M | 0.24% | 79 |
|
|
2015
Q1 | $382M | Sell |
3,310,990
-402,734
| -11% | -$46.4M | 0.26% | 71 |
|
|
2014
Q4 | $415M | Buy |
+3,713,724
| New | +$415M | 0.29% | 59 |
|